Literature DB >> 11544278

Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism.

O G Opitz1, Y Suliman, W C Hahn, H Harada, H E Blum, A K Rustgi.   

Abstract

The immortalization of human cells is a critical step in multistep carcinogenesis. Oral-esophageal carcinomas, a model system to investigate molecular mechanisms underlying squamous carcinogenesis, frequently involve cyclin D1 overexpression and inactivation of the p53 tumor suppressor. Therefore, our goal was to establish the functional role of cyclin D1 overexpression and p53 inactivation in the immortalization of primary human oral squamous epithelial cells (keratinocytes) as an important step toward malignant transformation. Cyclin D1 overexpression alone was found to induce extension of the replicative life span of normal oral keratinocytes, whereas the combination of cyclin D1 overexpression and p53 inactivation led to their immortalization. This study also demonstrates that immortalization of oral keratinocytes can be independent of telomerase activation, involving an alternative pathway of telomere maintenance (ALT).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544278      PMCID: PMC209376          DOI: 10.1172/JCI11909

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

2.  Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase.

Authors:  M J McEachern; E H Blackburn
Journal:  Genes Dev       Date:  1996-07-15       Impact factor: 11.361

3.  Human cyclin D1 oncogene and esophageal squamous cell carcinoma.

Authors:  H Nakagawa; L Zukerberg; K Togawa; S J Meltzer; T Nishihara; A K Rustgi
Journal:  Cancer       Date:  1995-08-15       Impact factor: 6.860

Review 4.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

5.  Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts.

Authors:  E M Rogan; T M Bryan; B Hukku; K Maclean; A C Chang; E L Moy; A Englezou; S G Warneford; L Dalla-Pozza; R R Reddel
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

Review 6.  Molecular biology of human oral cancer.

Authors:  D T Wong; R Todd; T Tsuji; R B Donoff
Journal:  Crit Rev Oral Biol Med       Date:  1996

7.  Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients.

Authors:  J Califano; S A Ahrendt; G Meininger; W H Westra; W M Koch; D Sidransky
Journal:  Cancer Res       Date:  1996-12-15       Impact factor: 12.701

Review 8.  SV40-induced immortalization of human cells.

Authors:  T M Bryan; R R Reddel
Journal:  Crit Rev Oncog       Date:  1994

9.  Telomerase activation by the E6 gene product of human papillomavirus type 16.

Authors:  A J Klingelhutz; S A Foster; J K McDougall
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

10.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

View more
  26 in total

1.  An alternative lifestyle for immortalized oral keratinocytes.

Authors:  R R Reddel
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance.

Authors:  Zaineb R Abdul Razak; Robert J Varkonyi; Michelle Kulp-McEliece; Corrado Caslini; Joseph R Testa; Maureen E Murphy; Dominique Broccoli
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  Cellular senescence requires CDK5 repression of Rac1 activity.

Authors:  Kamilah Alexander; Hai-Su Yang; Philip W Hinds
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 4.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

5.  Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres.

Authors:  Tania Slatter; Jennifer Gifford-Garner; Anna Wiles; Xin Tan; Yu-Jen Chen; Martin MacFarlane; Michael Sullivan; Janice Royds; Noelyn Hung
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

6.  Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.

Authors:  Masood A Shammas; Aamer Qazi; Ramesh B Batchu; Robert C Bertheau; Jason Y Y Wong; Manjula Y Rao; Madhu Prasad; Diptiman Chanda; Selvarangan Ponnazhagan; Kenneth C Anderson; Christopher P Steffes; Nikhil C Munshi; Immaculata De Vivo; David G Beer; Sergei Gryaznov; Donald W Weaver; Raj K Goyal
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

7.  Smart cell-specific protein therapeutics for head and neck cancer.

Authors:  Gulshan Sunavala-Dossabhoy
Journal:  Oral Dis       Date:  2019-10-27       Impact factor: 3.511

8.  Correlation of dyskerin expression with active proliferation independent of telomerase.

Authors:  Faizan Alawi; Ping Lin; Barry Ziober; Reena Patel
Journal:  Head Neck       Date:  2010-12-08       Impact factor: 3.147

Review 9.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

10.  Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication.

Authors:  Priya Aggarwal; Matthew D Lessie; Douglas I Lin; Laura Pontano; Andrew B Gladden; Beth Nuskey; Ami Goradia; Mariusz A Wasik; Andres J P Klein-Szanto; Anil K Rustgi; Craig H Bassing; J Alan Diehl
Journal:  Genes Dev       Date:  2007-11-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.